Seres Therapeutics (MCRB) Earnings
|
Expand Research on MCRB
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -759.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +5.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/25  |
Q325 | N/A | -$0.04 | N/A | N/A | $7.83M | N/A | N/A | N/A | ||
| 11/5/25 | Q325 | $0.94 | $0.00 | +$0.94 | $350K | N/A | N/A |  | | Details | |
| 8/6/25 |
Q225 | -$2.27 | -$0.09 | -$2.18 | N/A | $5M | N/A | | | Details | |
| 5/7/25 |
Q125 | N/A | $0.07 | N/A | N/A | $20M | N/A | N/A | N/A | ||
| 3/13/25 | Q424 | -$0.81 | -$0.20 | -$0.61 | N/A | N/A | N/A | | | Details | |
| 11/13/24 | Q324 | -$0.33 | -$0.08 | -$0.25 | N/A | $25.83M | N/A | | | Details | |
| 11/6/24 |
Q324 | N/A | -$0.08 | N/A | N/A | $25.83M | N/A | N/A | N/A | ||
| 8/13/24 | Q224 | -$0.22 | -$0.27 | +$0.05 | N/A | $-263830000000 | N/A | | | Details |
